A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Recruiting

Phase 2

Phase 3

PF-07275315A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Sponsor:

Pfizer

Code:

NCT07363694

Conditions

Moderate to Severe Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 35 - 70+

Healthy Volunteers: Not accepted

Interventions

PF-07275315 dose 1

PF-07275315-dose 2

Placebo

PF-07275315-dose 3

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-09. This information was provided to ClinicalTrials.gov by Pfizer on 2026-03-27.